Published in Acta Neuropathol on January 01, 1987
Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med (1956) 6.65
Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med (1955) 5.81
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies. Lab Invest (1969) 1.82
The effects of influenza on host defenses. J Infect Dis (1981) 1.54
An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol (1984) 1.30
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Identification of the neuritogen for experimental allergic neuritis. Nature (1979) 1.21
A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol (1984) 1.21
Demyelination in allergic and Marek's disease virus induced neuritis. Comparative electron microscopic studies. Acta Neuropathol (1977) 1.15
Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science (1985) 1.13
Early changes in experimental allergic neuritis. Lab Invest (1983) 1.09
National surveillance for Guillain-Barré syndrome: January 1978-March 1979. Neurology (1983) 1.03
Epstein-Barr virus and Guillain-Barré syndrome. Lancet (1972) 1.03
Mechanisms of action by immunologic adjuvants. J Am Vet Med Assoc (1982) 0.95
Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats. Lab Invest (1985) 0.94
Augmentation of immune-mediated demyelination by lipid haptens. Lab Invest (1981) 0.93
The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability. J Neurol Sci (1984) 0.89
Protection against experimental allergic neuritis with silica quartz dust. J Neuroimmunol (1982) 0.87
Quantitation of mast cells in experimental allergic neuritis. J Neuropathol Exp Neurol (1985) 0.86
Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett (1976) 0.86
Experimental allergic neuritis: demyelination induced by P2 alone and non-specific enhancement by cerebroside. J Neuropathol Exp Neurol (1984) 0.84
Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells. J Immunol (1985) 0.83
Antigen-specific demyelination and significance of the bystander effect in peripheral nerves. Am J Pathol (1984) 0.81
Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain-Barré syndrome. J Neuroimmunol (1984) 0.81
Guillain-Barré syndrome: epidemiology of an outbreak. Am J Epidemiol (1978) 0.81
Restoration of activity for induction of experimental allergic peripheral neuritis by a combination of myelin basic protein P2 and gangliosides from peripheral nerve. Neurosci Lett (1978) 0.79
Production of high titer antisera against sialoglycosphingolipids and their characterization using sensitized liposome. Jpn J Exp Med (1974) 0.78
The swine flu incident revisited. Ann Neurol (1984) 0.78
Experimental allergic neuritis-like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun (1983) 0.77
Lipid content of swine influenza and other vaccines. Lipids (1986) 0.77
Autonomic nerves in experimental allergic neuritis in the rat. Acta Neuropathol (1985) 0.77
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Controlled trial prednisolone in acute polyneuropathy. Lancet (1978) 3.71
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet (1988) 3.21
Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology (1992) 3.15
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation (1990) 2.74
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry (1988) 2.56
Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1997) 2.52
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) (2004) 2.37
Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol (1992) 2.21
Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science (1989) 2.19
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest (1992) 2.12
Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology (1987) 2.11
Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry (1998) 2.07
The psychometric properties of clinical rating scales used in multiple sclerosis. Brain (1999) 2.06
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler (1999) 2.02
Imaging in transient regional osteoporosis. Br J Rheumatol (1997) 2.01
Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med (1991) 2.01
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med (1972) 1.87
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med (1993) 1.67
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother (1991) 1.67
HIV and HCMV coinfect brain cells in patients with AIDS. Virology (1988) 1.65
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2000) 1.62
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol (1995) 1.60
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. J Neuropathol Exp Neurol (1974) 1.60
Chemokines and receptors in HIV encephalitis. AIDS (1998) 1.59
Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med (1990) 1.57
Trigeminal sensory neuropathy. A study of 22 cases. Brain (1987) 1.56
Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol (1982) 1.56
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med (2000) 1.55
Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol (1992) 1.51
Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry (2000) 1.50
Guillain-Barré syndrome after treatment with streptokinase. BMJ (1992) 1.48
A case of fatal peri-partum cardiomyopathy. Br Heart J (1970) 1.46
Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.43
HTLV-1 in acquired adult myopathy. Muscle Nerve (1993) 1.42
Acute inflammatory polyneuropathy. Br J Hosp Med (1978) 1.42
Vasculitic neuropathy in association with chronic graft-versus-host disease. J Neurol Sci (1999) 1.41
Nosocomial febrile illnesses in patients on an internal medicine service. Arch Intern Med (1989) 1.41
Clinical scales for multiple sclerosis. J Neurol Sci (1996) 1.39
Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol (1983) 1.39
T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol (1990) 1.38
Intravenous IgG in Guillain-Barré syndrome. BMJ (1996) 1.38
Chronic relapsing axonal neuropathy: a first case report. Ann Neurol (1995) 1.38
Experimental syphilitic orchitis in rabbits: ultrastructural appearance of Treponema pallidum during phagocytosis and dissolution by macrophages in vivo. Lab Invest (1982) 1.37
The effects of methotrexate on pregnancy, fertility and lactation. QJM (1999) 1.36
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Prognosis in Guillain-Barré syndrome. Lancet (1985) 1.33
Enzyme-linked immunosorbent assay for detection of specific antibodies to Ureaplasma urealyticum serotypes. J Clin Microbiol (1984) 1.33
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain (2001) 1.32
Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J Cell Biol (1991) 1.30
Glycogen accumulation in the nerves and kidney of chronically diabetic rats. A quantitative electron microscopic study. J Neuropathol Exp Neurol (1979) 1.30
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol (1999) 1.28
Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res (1999) 1.28
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry (1999) 1.27
The course of patients with suspected myocardial infarction. The identification of low-risk patients for early transfer from intensive care. N Engl J Med (1980) 1.27
Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26
Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology (1986) 1.26
Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest (1993) 1.25
Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol (1995) 1.24
Plasma exchange for Guillain-Barré syndrome. Br Med J (Clin Res Ed) (1985) 1.24
Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun (1988) 1.23
The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology (1973) 1.23
Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J (1998) 1.23
Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages. J Virol (1993) 1.22
Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia (2004) 1.21
Identification of the neuritogen for experimental allergic neuritis. Nature (1979) 1.21
Reliability of distance estimation by doctors and patients: cross sectional study. BMJ (1998) 1.21
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2002) 1.20
Relationship of optic disc topography to optic nerve fiber number in glaucoma. Arch Ophthalmol (1998) 1.19
Role of opportunistic viral infections in AIDS. AIDS (1990) 1.19
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol (1991) 1.19
Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange. J Neurol (1982) 1.19
Pathology of experimental nerve compression. Lab Invest (1986) 1.19
Brain viral burden in HIV infection. J Neuropathol Exp Neurol (1994) 1.18
Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses (1996) 1.18
Ciliary neurotrophic factor. J Neurobiol (1994) 1.17
Microangiopathy in human diabetic neuropathy. Acta Neuropathol (1985) 1.17
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J Exp Med (1995) 1.17
Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome). Clin Exp Immunol (1983) 1.17